BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31895743)

  • 21. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis.
    Miura E; Procianoy RS; Bittar C; Miura CS; Miura MS; Mello C; Christensen RD
    Pediatrics; 2001 Jan; 107(1):30-5. PubMed ID: 11134430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BAL induces an increase in peripheral blood neutrophils and cytokine levels in healthy volunteers and patients with pneumonia.
    Terashima T; Amakawa K; Matsumaru A; van Eeden S; Hogg JC; Yamaguchi K
    Chest; 2001 Jun; 119(6):1724-9. PubMed ID: 11399697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.
    Weiss M; Voglic S; Harms-Schirra B; Lorenz I; Lasch B; Dumon K; Gross-Weege W; Schneider EM
    Intensive Care Med; 2003 Jun; 29(6):904-914. PubMed ID: 12682721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
    Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
    J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulocyte-colony stimulating factor levels in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis.
    Ashitani J; Mukae H; Taniguchi H; Ihi T; Kadota J; Kohno S; Matsukura S
    Thorax; 1999 Nov; 54(11):1015-20. PubMed ID: 10525561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.
    Wislez M; Fleury-Feith J; Rabbe N; Moreau J; Cesari D; Milleron B; Mayaud C; Antoine M; Soler P; Cadranel J
    Am J Pathol; 2001 Oct; 159(4):1423-33. PubMed ID: 11583970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adhesion molecules, endogenous granulocyte colony-stimulating factor levels and replating capacity of progenitors in autoimmune neutropenia of childhood.
    Perdikogianni Ch; Dimitriou H; Stiakaki E; Markaki EA; Kalmanti M
    Acta Paediatr; 2003 Nov; 92(11):1277-83. PubMed ID: 14696847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Principal components derived from CSF inflammatory profiles predict outcome in survivors after severe traumatic brain injury.
    Kumar RG; Rubin JE; Berger RP; Kochanek PM; Wagner AK
    Brain Behav Immun; 2016 Mar; 53():183-193. PubMed ID: 26705843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Granulocyte colony-stimulating factor: A relation between serum and follicular fluid levels and in-vitro fertilization outcome in patients with polycystic ovary syndrome.
    Kahyaoglu I; Yılmaz N; Timur H; Inal HA; Erkaya S
    Cytokine; 2015 Jul; 74(1):113-6. PubMed ID: 25258001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
    Shimazaki C; Uchiyama H; Fujita N; Araki S; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Haruyama H
    Exp Hematol; 1995 Dec; 23(14):1497-502. PubMed ID: 8542937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem Cell Factor and Granulocyte Colony-Stimulating Factor Promote Remyelination in the Chronic Phase of Severe Traumatic Brain Injury.
    Qiu X; Ping S; Kyle M; Chin L; Zhao LR
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum concentrations of granulocyte colony-stimulating factor (G-CSF) determined by a highly-sensitive chemiluminescent immunoassay during the clinical course of subacute thyroiditis.
    Sakane S; Murakami Y; Sasaki M; Yamano Y; Takamatsu J; Kuma K; Ohsawa N
    Endocr J; 1995 Jun; 42(3):391-6. PubMed ID: 7545505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of granulocyte colony-stimulating factor on functional and histopathologic outcome after traumatic brain injury in mice.
    Sheibani N; Grabowski EF; Schoenfeld DA; Whalen MJ
    Crit Care Med; 2004 Nov; 32(11):2274-8. PubMed ID: 15640641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous subcutaneous injection reduces polymorphonuclear leukocyte activation by granulocyte colony-stimulating factor.
    Sato Y; Goto Y; Sato S; Endo S; Sohara Y
    Am J Physiol Lung Cell Mol Physiol; 2004 Jan; 286(1):L143-8. PubMed ID: 14527931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A study of the effects of chemotherapy with or without G-CSF on neutrophil counts and serum G-CSF levels in leukemia patients].
    Chen S; Zhang Z; Liu P
    Zhonghua Nei Ke Za Zhi; 1996 Apr; 35(4):249-52. PubMed ID: 9387641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient leukocytosis, granulocyte colony-stimulating factor plasma concentrations, and apoptosis determined by binding of annexin V by peripheral leukocytes in patients with severe sepsis.
    Weiss M; Elsharkawi M; Welt K; Schneider EM
    Ann N Y Acad Sci; 2003 Dec; 1010():742-7. PubMed ID: 15033821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
    Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
    Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of granulocyte colony-stimulating factor treatment on ex vivo neutrophil functions in nonneutropenic surgical intensive care patients.
    Gerber A; Struy H; Weiss G; Lippert H; Ansorge S; Schulz HU
    J Interferon Cytokine Res; 2000 Dec; 20(12):1083-90. PubMed ID: 11152575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of vascular endothelial growth factor and vascular endothelial growth inhibitor in clinical outcome of traumatic brain injury.
    Li M; Jia Q; Chen T; Zhao Z; Chen J; Zhang J
    Clin Neurol Neurosurg; 2016 May; 144():7-13. PubMed ID: 26945876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term beneficial effects of hematopoietic growth factors on brain repair in the chronic phase of severe traumatic brain injury.
    Qiu X; Ping S; Kyle M; Chin L; Zhao LR
    Exp Neurol; 2020 Aug; 330():113335. PubMed ID: 32360282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.